an increasing trendp = 0.06
A higher remission rate in the active tDCS group, compared with the sham tDCS group, supported the efficacy of this treatment (Day 3: an increasing trend, p = 0.06; Week 1, Week 2, and Week 3: p < 0.05).
A higher remission rate in the active tDCS group, compared with the sham tDCS group, supported the efficacy of this treatment (Day 3: an increasing trend, p = 0.06; Week 1, Week 2, and Week 3: p < 0.05).